FDA
-
-
-
-
-
-
-
22nd Century Group, Inc. Highlights FDA Filing of VLN® MRTP Renewal Applications for Scientific Review
-
-
-
-
-
-
-
22nd Century Advances Reduced Nicotine Product to Target Approximately Half of the ~$82 Billion U.S. Cigarette Market with 100mm VLN® Product Initiative
-
-
-
-
-
-
-
22nd Century Group reports $17.6 million revenue for 2025
-
-
-
-
-
-
-
22nd Century to Participate in the Emerging Growth Conference on December 10, 2025
-
-
-
-
-
-
-
22nd Century Submits Comments to FDA in Support of Proposed Reduced Nicotine Content Mandate
-
-
-
-
-
-
-
22nd Century CEO & Chairman Larry Firestone Provides Technology and Regulatory Update Letter to Stockholders
-
-
-
-
-
-
-
22nd Century Reports Expanded State Authorization Progress to Sell VLN®, Partner VLN® and Conventional Products
-
327,952 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

